Connect with us

National

Top Matabeleland North ranger’s crusade to curb wildlife crimes

Published

on

BY NOKUTHABA DLAMINI

A senior Zimbabwe Parks and Wildlife Management Authority (Zimparks) officer is going beyond the call of duty to educate communities about wildlife crimes to curb cases of poaching.

Advertisement

Amos Gwema, a principal wildlife investigation and security officer, said he was pushed to do the awareness campaigns after a realisation that criminal syndicates tend to take advantage of poor villagers by luring them into poaching in return for a small fee.

Gwema said communities living around the Hwange National Park – the largest game reserve in Zimbabwe – were vulnerable to manipulation by the poaching syndicates.

In 2013, eight villagers from Hwange and Tsholotsho districts were jailed in connection with the deaths of tens of elephants at the Hwange National Park, which were poisoned with cyanide.

Advertisement

Several villagers in Matabeleland North have also been arraigned before the courts in Hwange and Victoria Falls after they were found in possession of ivory.

Gwema said he decided to carry out the awareness activities two years ago after winning a major award.

“In 2020 after I won the Tusk Ranger of the Year award I pledged to do awareness campaigns to inform the public about the dangers of committing wildlife crimes,” he said.

Advertisement

“I had realised that some community members were being taken advantage of by urban dwellers, who promise them hefty rewards for elephant ivory and pangolins.

“The community members are not being told about the dangers of committing wildlife crimes, hence the aim of my awareness campaigns is to inform the community members about the other side so that they will make informed choices.”

In Zimbabwe, possession of ivory or  a pangolin attracts a minimum mandatory sentence of nine years and Gwema said villagers in areas such as Binga, Hwange and Tsholotsho are often lured into poaching by syndicates from neighbouring Zambia or from urban areas.

Advertisement

According to court records, 14 people were arrested in the three districts after they were caught with ivory between January and June this year.

Among them were four villagers from Binga and Hwange who were arrested alongside a Zambian national after they were found with four elephant tusks, which they were trying to sell on the streets of Kamativi.

The suspects included villagers aged 67 and 65.

Advertisement

“There is a danger of being shot dead and also the young ones can lose personal savings through legal fees and in the end still go to jail,” Gwema said.

“So this is what pushed me to do wildlife awareness campaigns to inform the public that crime does not pay at all, but you will lose out and go to jail.

The top ranger has become famous in the communities for his slogan “If you see something say something and do something.”

Advertisement

Gwema said this was meant to encourage people to report wildlife crimes as soon as they see them being committed in their areas.

He moves around schools in Matabeleland North province teaching children about the importance of wildlife conservation.

“So far I have donated 250 books in Hwange, Binga, Tsholotsho, Lupane and I am waiting for a delivery of other books from the Pan African Conservation Education (PACE) which we donate for free,” Gwema added.

Advertisement

In some areas the awareness campaigns are so successful such that villagers end up volunteering information about poachers operating in their areas, he said.

“They also inform the authorities about the presence of those who sell game meat in the community,” Gwema added.

“This have resulted in the arrest of poachers outside the protected areas whereby ivory, firearms, cyanide, snares were recovered.

Advertisement

“This has also resulted in poaching cases going down, especially around the Hwange National Park and I believe that communities are our first line of defence for effective wildlife conservation.”

His goal is spread the campaigns across the country and into the region, but he is constrained by limited funding.

He said the media could be used more effectively to educate people about wildlife crimes and the penalties.

Advertisement

“When someone is convicted for a wildlife crime I propose that (authorities) issue a media statement in vernacular languages so that the message could be understood by all,” Gwema added.

“That will greatly help our people to desist from committing wildlife crimes and thus helps conserve our wildlife.”

His efforts have not gone unnoticed as he was early this year given the Lifetime Award in Conservation by Bhejane Trust and other conservations groups in Victoria Falls.

Advertisement

In 2019, he won the Rhino Conservation Award, which was a special recognition for his contribution to endangered species conservation.

Some of his achievements in the past 10 years include smoking out poachers that had stashed ivory at a guest house.

He also orchestrated the arrest of a teacher, who was trading ivory for cooking oil.

Advertisement

Gwema was behind the arrest of 150 people that had committed wildlife crimes, which led to successful convictions.

He works closely with Bhejane Trust, Save the Africa Rhino Foundation, Shangano Arts, PACE, Tusk UK and Zimparks director-general Fulton Mankwanya who offer him guidance in conservation.

Advertisement
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

National

Tragic attack in Madlambuzi: Five dead as suspected mental patient goes on rampage

Published

on

BY WANDILE TSHUMA 

Police in Madlambuzi, Matabeleland South Province has are a suspected mental patient, Phamani Sibanda, following a violent rampage that left five people dead and two others injured on Wednesday.

Advertisement

According to the police statement, Sibanda (43) allegedly attacked seven people in the village using a Mopani log, a blunt object, and an unknown sharp weapon, targeting anyone who crossed his path.

The victims of this tragic attack have been identified by their next of kin:

Elliot Khupe, 101, a male adult from Bellas Village
Butho Tshuma, 97, a female adult from Bellas Village
Constance Sibanda, 66, a female adult from Bellas Village
Tiffan Surprise Ndlovu, 6, a female juvenile from Bellas Village
Catra Matsika, 72, from Central Village

Advertisement

In addition to the fatalities, two other women, aged 90 and 41, sustained injuries and are currently receiving treatment at Madlambuzi Clinic and Plumtree District Hospital.

The ZRP has underscored the pressing need for community awareness regarding mental health issues. “We implore the public to promptly refer mental patients to medical institutions for treatment and to actively monitor their behavior to prevent such violent incidents,” the statement elaborated. It encouraged community members to report any concerns to the National Complaints Desk at (0242) 703631 or via WhatsApp at 0712 800197, or to approach the nearest police station.

 

Advertisement

Continue Reading

National

US suspends visa processing in Zimbabwe, embassy says

Published

on

BY REUTERS

The United States has stopped processing most visas in Zimbabwe until further notice, its embassy in the capital Harare said on Wednesday, citing unspecified concerns with the government.
“We have paused routine visa services in Harare while we address concerns with the Government of Zimbabwe,” the embassy said in a post on X. It said the move was not a travel ban and that current visas would remain valid.
The government of the Southern African country did not immediately reply to a request for comment.
The pause took effect on August 7, according to a notice on the U.S. State Department’s website, which said it applied to all visa services with the exception of most diplomatic and official visas.
U.S. President Donald Trump’s administration has restricted travel from a number of African countries, saying it is working to prevent visa overstaying and misuse.
Zimbabwe had a visa overstay rate of 10.57% in 2023, according to a U.S. Department of Homeland Security report.
Starting this week, the U.S. will require visa applicants from Zambia and Malawi to pay bonds of up to $15,000 for some visitor visas. The Trump administration has also paused visa processing in Niger.
Harare resident Angella Chirombo said her 18-year-old son had received a scholarship to do his bachelor’s degree at Michigan State University and had been waiting for a visa interview when the pause hit.
“He was supposed to be in school already. I paid for everything else and was waiting for the visa so I could buy tickets,” she told Reuters.
She said other parents were considering booking interviews at other U.S. embassies in Southern Africa, but that she wouldn’t be able to afford the travel.
“Now they are saying we can go to Zambia and Namibia. I don’t even have money right now and I don’t know where to get this money. They are so many students that have been affected.”

Continue Reading

National

Landmark HIV trial begins in Zimbabwe

Published

on

BY PAUL SIXPENCE

ZIMBABWE became the first site for the administration of a new investigational HIV vaccine. The first doses of the IAVI C114 clinical trial were administered in late July 2025 at the Mutala Trust clinical site in Harare, CITE reports.

Advertisement

“This is a landmark moment for South Africa, Zimbabwe, and the continent. It shows the power of true partnership,” said Dr. Tariro Makadzange, clinical trial lead, Mutala Trust.

“We are edging closer to an HIV vaccine, made possible by global collaboration, with clinical trials conducted in Africa, for Africa, and for the world.”

The development of the vaccine is a partnership that brings together Zimbabwe’s Mutala Trust, ReiThera, the Ragon Institute, International AIDS Vaccine Initiative (IAVI) and African researchers who are co-leading every phase of the trial.

Advertisement

In phase one of the trial, the vaccine candidate, Gorilla Adenovirus Vectored HIV Networked Epitopes Vaccine (GRAdHIVNE1) will be administered to 120 adults between the ages of 18 and 50 years including 48 people living with HIV who are virally suppressed on antiretroviral therapy (ART). Besides Zimbabwe, two other clinical trial sites are located in Cape Town and Durban, South Africa.

Trial sites were chosen on the basis of their high HIV burden and to ensure that the vaccine candidate is tested within communities affected by the epidemic.

This phase of the trial will assess the safety and ability of the vaccine candidate to provoke an immune response in the human body in persons living with HIV and those who are HIV negative.

Advertisement

“The IAVI C114 trial is testing a new vaccine candidate known as GRAdHIVNE1. The trial represents the first time this vaccine is being tested in humans and is aimed at assessing the safety of the vaccine and its ability to stimulate the immune system,” said Dr. Vincent Muturi-Kioi, HIV Vaccines Product Development Team Lead, IAVI.

In a statement, IAVI further advised that “trial participants will receive either one or two doses of the investigational vaccine or a placebo and will be monitored over a period of 19 months for safety and immune responses.” Results of the trial are likely to be available in 2027.

In the past, several HIV vaccine trials have been conducted but none proved effective in preventing HIV acquisition. The novelity of this vaccine candidate lies in that, it uses a harmless viral vector to deliver small parts of HIV “derived from critical structural regions of HIV that are less likely to mutate” with an expected likelihood to trigger an immune response.

Advertisement

“GRAdHIVNE1 uses a harmless virus (a vector for the vaccine derived from a non-replicating gorilla adenovirus) to deliver small, conserved parts of HIV (called epitopes) to the body’s immune system. These targets are derived from critical structural regions of HIV that are less likely to mutate, making them good targets for killer T cells in the immune system (CD8+ T cell responses) — a type of immune defense thought to be important for long-term protection against HIV. The viral vector was selected based on its ability to stimulate this type of response. Should the vaccine be successful in stimulating the desired response, it could be tested in future trials to assess its efficacy,” Dr. Vincent Muturi-Kioi further explained.

The initiation of this clinical trial demonstrates the power of partnerships at a time when the world is witnessing funding cuts towards global public health research. The IAVIC114 clinical trial is sponsored by IAVI. The vaccine candidate, GRAdHIVNE1, was developed by ReiThera and the Ragon Institute with funding from the GatesFoundation. African researchers will be leading

SOURCE| CITE

Advertisement

Continue Reading

Trending

Copyright © 2022 VicFallsLive. All rights reserved, powered by Advantage